Comparison of Outcomes of Patients with vs without Previous Coronary Artery Bypass Graft Surgery Presenting with

Judit Karacsonyi1, Christian W Schmidt1, Brynn K Okeson1

  • 1Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Insights

Patients with prior coronary artery bypass graft (CABG) surgery experiencing ST-segment elevation myocardial infarction (STEMI) face worse long-term outcomes, including higher mortality and major adverse cardiac events, even after accounting for other risk factors.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Outcomes for ST-segment elevation acute myocardial infarction (STEMI) patients with prior coronary artery bypass graft (CABG) surgery are not well-established.
  • Limited research exists on the specific clinical and procedural characteristics of STEMI patients with a history of CABG.

Purpose of the Study:

  • To compare the clinical characteristics, procedural aspects, and long-term outcomes of STEMI patients with and without previous CABG.
  • To identify if previous CABG is an independent predictor of mortality and major adverse cardiac events (MACE) after STEMI.

Main Methods:

  • Analysis of a contemporary multicenter STEMI registry (2003-2020).
  • Inclusion of 13,893 STEMI patients, with 7.2% having prior CABG.
  • Kaplan-Meier survival analysis and log-rank tests to compare outcomes; multivariable adjustment for baseline characteristics.

Main Results:

  • Previous CABG patients were older, more frequently male, and had higher rates of diabetes.
  • Patients with prior CABG experienced significantly higher 5-year mortality and MACE (death, myocardial infarction, stroke) compared to those without.
  • Prior CABG was independently associated with increased mortality from discharge to 18 months and 18 months to 5 years post-STEMI.

Conclusions:

  • Long-term outcomes following STEMI are poorer in patients with a history of CABG.
  • Previous CABG is a significant independent predictor of adverse outcomes after STEMI, underscoring the need for tailored management strategies.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
55
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
97
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
191
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
81
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
79